MLICM
GNCA

Metropolitan Life Insurance Company (MetLife)’s Genocea Biosciences, Inc. GNCA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,798
Closed -$99K – 2664
2015
Q3 		$99K Hold
1,798
– – ﹤0.01% 2583
2015
Q2 		$198K Buy
+1,798
New +$167K ﹤0.01% 2408

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s GNCA Position: Q4 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2015, closing a stake of 1,798 shares — an estimated $99K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GNCA in Q2 2015 and held it in 2 quarters. The position peaked at $198K in Q2 2015. 57 funds tracked by Wall St. Rank hold GNCA as of Q4 2015.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Genocea Biosciences, Inc. position as of Q4 2015 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,798 Genocea Biosciences, Inc. shares in Q4 2015, an estimated $99K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Genocea Biosciences, Inc. in Q2 2015 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Genocea Biosciences, Inc. position peaked at $198K in Q2 2015.
  • 57 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2015, filed 11 Feb 2016.